Healthcare - Biotechnology - NYSE - US
$ 2.63
-8.36 %
$ 885 M
Market Cap
-1.21
P/E
Price Target
Average
166.16%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
18.92%
Net Income
Estimate
20.26%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Nuvation Bio Inc.
Wall Street analysts predict an average 1-year price target for NUVB of $7 , with forecasts ranging from a low of $5 to a high of $10 .
NUVB Lowest Price Target
Wall Street Target
5 USD
90.11%
NUVB Average Price Target
Wall Street Target
7 USD
166.16%
NUVB Highest Price Target
Wall Street Target
10 USD
280.23%
REVENUE FORECAST
Revenue Forecast Chart NUVB
EBIT FORECAST
EBIT Forecast Chart NUVB
NET INCOME FORECAST
Net Income Chart NUVB